Review article · 2022 · Open access

Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five

Sven Stegemann, Chris Moreton, Sami Svanbäck, Karl J. Box, Geneviève Motte, Amrit Paudel

Drug Discovery Today, 28(2), 103344 · Published 25 November 2022 · DOI 10.1016/j.drudis.2022.103344

Read the free full textCite this paper

In brief

“Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five” is a 2022 review article by Sven Stegemann and 5 co-authors, published in Drug Discovery Today. OpenAlex counts 83 citations as of 15 November 2026, which puts it in the top 1% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Drug Discovery Today.

Citations
83
Most cited in
2026 (31)
Field-weighted impact
1.06
References
89
Authors
6

Abstract

In 1997, the 'Rule of Five' (Ro5) suggested physicochemical limitations for orally administered drugs, based on the analysis of chemical libraries from the early 1990s. In this review, we report on the trends in oral drug product development by analyzing products launched between 1994 and 1997 and between 2013 and 2019. Our analysis confirmed that most new oral drugs are within the Ro5 descriptors; however, the number of new drug products of drugs with molecular weight (MW) and calculated partition coefficient (clogP) beyond the Ro5 has slightly increased. Analysis revealed that there is no single scientific or technological reason for this trend, but that it likely results from incremental advances are being made in molecular biology, target diversity, drug design, medicinal chemistry, predictive modeling, drug metabolism and pharmacokinetics, and drug delivery.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Stegemann, S., Moreton, C., Svanbäck, S., Box, K. J., Motte, G., & Paudel, A. (2022). Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five. Drug Discovery Today, 28(2), 103344. https://doi.org/10.1016/j.drudis.2022.103344

MLA 9

Stegemann, Sven, et al. “Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five.” Drug Discovery Today, vol. 28, no. 2, 2022, p. 103344. https://doi.org/10.1016/j.drudis.2022.103344.

Chicago

Stegemann, Sven, Chris Moreton, Sami Svanbäck, Karl J. Box, Geneviève Motte, and Amrit Paudel. 2022. “Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five.” Drug Discovery Today 28 (2): 103344. https://doi.org/10.1016/j.drudis.2022.103344.

Harvard

Stegemann, S. et al. (2022) ‘Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five’, Drug Discovery Today, 28(2), p. 103344. doi:10.1016/j.drudis.2022.103344.

IEEE

S. Stegemann, C. Moreton, S. Svanbäck, K. J. Box, G. Motte, and A. Paudel, “Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five,” Drug Discovery Today, vol. 28, no. 2, p. 103344, 2022, doi: 10.1016/j.drudis.2022.103344.

BibTeX

@article{stegemann2022trends,
  title     = {{Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five}},
  author    = {Stegemann, Sven and Moreton, Chris and Svanbäck, Sami and Box, Karl J. and Motte, Geneviève and Paudel, Amrit},
  journal   = {Drug Discovery Today},
  year      = {2022},
  volume    = {28},
  number    = {2},
  pages     = {103344},
  doi       = {10.1016/j.drudis.2022.103344},
  url       = {https://doi.org/10.1016/j.drudis.2022.103344}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20231111
20241818
20252323
20263131

Its field-weighted citation impact is 1.06: it has been cited 1.06 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • Lipinski's rule of five
  • oral small-molecule drug
  • pharmaceutical product development
  • drug launch
  • molecular weight
  • octanol-water partition coefficient
  • physicochemical properties
  • drug metabolism

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Stegemann, S., Moreton, C., Svanbäck, S., Box, K. J., Motte, G., & Paudel, A. (2022). Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five. Drug Discovery Today, 28(2), 103344. https://doi.org/10.1016/j.drudis.2022.103344

How many times has this paper been cited?

83 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Drug Discovery Today.

Who wrote this paper?

Sven Stegemann, Chris Moreton, Sami Svanbäck, Karl J. Box, Geneviève Motte, Amrit Paudel.

What is the DOI of this paper?

10.1016/j.drudis.2022.103344. The permanent link is https://doi.org/10.1016/j.drudis.2022.103344.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.